Dementia physically shrinks the brain, kills neurons, and destroys the connections between them. The damage typically begins years before symptoms appear, starting in regions responsible for memory and gradually spreading to areas that control language, reasoning, movement, and personality. What exactly goes wrong depends on the type of dementia, but all forms share a common outcome: progressive, irreversible loss of brain tissue and function.
How Damage Begins at the Cellular Level
In Alzheimer’s disease, which accounts for the majority of dementia cases, two abnormal proteins drive the destruction. The first, beta-amyloid, clumps together outside neurons into sticky deposits called plaques. The second, tau, twists into tangles inside neurons. Together, they form a destructive partnership: beta-amyloid triggers tau to shift from its normal, helpful state into a toxic one, and toxic tau then amplifies beta-amyloid’s damage through a feedback loop.
These proteins don’t just sit there. Soluble forms of beta-amyloid sever the structural scaffolding inside dendrites (the branches neurons use to receive signals) and block long-term potentiation, the process your brain uses to strengthen connections during learning. The result is that neurons can no longer talk to each other effectively. Synaptic loss, the breakdown of these communication points, is the earliest measurable change in Alzheimer’s and the strongest predictor of cognitive decline. Critically, synapses start failing and disappearing before neurons themselves die. Greater damage occurs at the signaling terminals of neurons than to the cell bodies, which means the wiring of the brain frays before the cells are gone entirely.
Where the Brain Shrinks First
The damage follows a remarkably consistent geographic pattern. In Alzheimer’s, it begins in the entorhinal cortex, a small region deep in the brain that serves as the main gateway to the hippocampus, the brain’s memory-forming center. From there, toxic tau spreads into the hippocampus itself, then outward to the surrounding temporal lobe, then to limbic structures involved in emotion, and finally across the entire outer surface of the brain, including frontal and parietal regions responsible for planning, judgment, and spatial awareness.
This spreading pattern explains why memory loss comes first. The hippocampus, which is essential for forming new short-term memories, undergoes rapid tissue loss in early Alzheimer’s. As the disease progresses, its internal layers lose volume bilaterally. By the time someone reaches moderate dementia, the hippocampus has visibly shrunk on brain scans, and the damage has expanded to cortical regions that govern language, decision-making, and the ability to recognize faces or navigate familiar places.
Chemical Signals Break Down
A healthy brain depends on a careful balance of chemical messengers. Dementia disrupts that balance profoundly. In Alzheimer’s, levels of glutamate, the brain’s primary excitatory messenger essential for learning and memory, drop significantly in the cortex, hippocampus, and temporal lobe. Levels of GABA, the main inhibitory messenger that keeps neural activity in check, also fall across multiple brain regions. This dual decline collapses the balance between excitation and inhibition that the cortex and hippocampus need to function properly.
Acetylcholine, another messenger critical for attention and memory, is also depleted early in the disease. The neurons that produce it are among the first to degenerate. This is why the earliest Alzheimer’s medications were designed to boost acetylcholine levels, though their effect is modest and temporary.
The Brain’s Immune System Turns Harmful
The brain has its own immune cells called microglia. Under normal conditions, microglia act as cleanup crews: they clear away dead cells, prune unnecessary synapses during development, and respond to injury. In dementia, they initially try to clear the accumulating protein deposits. But as the disease persists, their activation becomes chronic. Instead of resolving the problem, chronically activated microglia continuously release inflammatory molecules that damage surrounding neurons.
This sustained inflammation becomes self-perpetuating. The inflammatory response consistently outpaces the brain’s anti-inflammatory defenses, creating a toxic environment that accelerates neuron death beyond what the protein deposits alone would cause. Microglia produce more inflammatory signals than any other type of brain cell, making them the primary engine of this damaging cycle.
Vascular Dementia: Damage From Blood Flow
Not all dementia involves protein deposits. Vascular dementia, the second most common type, results from impaired blood flow to the brain. Chronic small vessel disease, often driven by high blood pressure or diabetes, damages the brain’s white matter, the insulated cables that connect different brain regions to one another.
The damage occurs through several mechanisms: reduced blood flow (hypoperfusion), breakdown of the blood-brain barrier, and physical changes to small blood vessels including loss of vessel density and thickening of vein walls. The brain’s “watershed zones,” areas at the far reaches of arterial supply where blood pressure is weakest, are especially vulnerable. When blood flow drops, these areas develop patches of damage visible on MRI as bright spots called white matter hyperintensities.
Mild lesions involve damage to the insulating coating around nerve fibers and enlarged spaces around blood vessels. More extensive lesions show actual loss of insulation, disruption of the nerve fibers themselves, and scarring. The damage to white matter near the brain’s fluid-filled ventricles is particularly severe, showing greater loss of nerve fibers and the cells that produce their insulation. One important consequence is that these lesions can sever the chemical signaling pathways running from deep brain structures to the cortex, disrupting attention and executive function even when the cortex itself appears intact.
How Other Types Differ
In Lewy body dementia, the culprit is a different protein called alpha-synuclein, which aggregates into round clumps inside neurons. These deposits appear in brain regions controlling both movement and cognition, which is why Lewy body dementia produces a distinctive combination of symptoms: visual hallucinations, fluctuating alertness, and Parkinson’s-like stiffness or tremor alongside memory problems. The same protein deposits are found in Parkinson’s disease, but when they spread widely through cortical areas, dementia results.
Frontotemporal dementia targets the frontal and temporal lobes specifically. Damage to the frontal lobe, which governs personality, social behavior, and impulse control, causes behavioral changes that can be mistaken for psychiatric illness: loss of empathy, compulsive behaviors, or inappropriate social conduct. Damage to the temporal lobe disrupts language, sometimes making it progressively harder to find words or understand speech. Unlike Alzheimer’s, memory often remains relatively intact in the early stages, which can delay diagnosis.
What Brain Scans Reveal
Modern imaging makes much of this damage visible. MRI scans show whether brain regions have atrophied, and repeated scans over time can track how quickly the shrinkage progresses. Doctors typically use MRI early in the diagnostic process, partly to rule out other causes of cognitive changes like bleeding or fluid buildup.
PET scans go further. Amyloid PET scans detect beta-amyloid plaques directly, making them useful for confirming Alzheimer’s. Tau PET scans can map the spread of tau tangles across the brain, though these are used more in specialized settings than in routine care. A third type, FDG PET, measures how actively different brain regions are using energy. People with dementia show abnormal patterns of reduced energy use in specific areas, and this scan is particularly helpful when doctors suspect frontotemporal dementia rather than Alzheimer’s, because the two diseases produce distinctly different energy-use patterns.
These tools have confirmed something important: the biological changes of dementia begin long before the first noticeable symptoms. Amyloid deposits can appear 15 to 20 years before memory loss begins, and measurable brain shrinkage is already underway by the time someone first visits a doctor with concerns about forgetfulness. By the time a person reaches a clinical diagnosis, substantial and irreversible damage has already occurred.